Burden of disease attributable to second-hand smoke exposure: A systematic review
Por:
Carreras, G, Lugo, A, Gallus, S, Cortini, B, Fernandez, E, Lopez, MJ, Soriano, JB, Lopez-Nicolas, A, Semple, S, Gorini, G, Castellano, Y, Fu, M, Ballbe, M, Amalia, B, Tigova, O, Continente, X, Arechavala, T, Henderson, E, Liu, XQ, Bosetti, C, Davoli, E, Colombo, P, O'Donnell, R, Dobson, R, Clancy, L, Keogan, S, Byrne, H, Behrakis, P, Tzortzi, A, Vardavas, C, Vyzikidou, VK, Bakellas, G, Mattiampa, G, Boffi, R, Ruprecht, A, De Marco, C, Borgini, A, Veronese, C, Bertoldi, M, Tittarelli, A, Verdi, S, Chellini, E, Trapero-Bertran, M, Guerrero, DC, Radu-Loghin, C, Nguyen, D, Starchenko, P, Ancochea, J, Alonso, T, Pastor, MT, Erro, M, Roca, A, Perez, P
Publicada:
1 dic 2019
Resumen:
Our aim was to provide a systematic review of studies on the burden of disease due to second-hand smoke (SHS) exposure, reviewing methods, exposure assessment, diseases causally linked to SHS, health outcomes, and estimates available to date.
A literature review of studies on the burden of disease from SHS exposure, available in PubMed and SCOPUS, published 2007-2018 in English language, was carried out following the PRISMA recommendations. Overall, 588 studies were first identified, and 94 were eligible.
Seventy-two studies were included in the systematic review. Most of them were based on the comparative risk assessment approach, assessing SHS exposure using mainly surveys on exposure at home/workplaces. Diseases more frequently studied were: lung cancer, ischemic heart disease, stroke, chronic obstructive pulmonary disease, asthma and breast cancer in adults; lower respiratory tract infection, otitis media, asthma, sudden infant death syndrome and low birth weight in children. The SHS exposure assessment and the reported population attributable fractions (PAF) were largely heterogeneous. As an example, the PAF from lung cancer varied between 0.6% and 20.5%. Moreover, PAF were estimated applying relative risks and SHS exposures with no consistent definitions or with different age classes.
The research gap on the SHS exposure burden is shrinking. However, estimates are not yet available for a number of countries, particularly the Middle Eastern and African countries, and not all diseases with the strongest evidence of causation, such as sudden infant death syndrome, have been explored. Moreover, in some cases the applied methodology revealed relatively low quality of data.
Filiaciones:
Carreras, G:
Oncol Network Prevent & Res Inst ISPRO, Via Cosiino Il Vecchio 2, I-50139 Florence, Italy
Lugo, A:
Ist Ric Farmacol Mario Negri IRCCS IRFMN, Via La Masa 19, I-20156 Milan, Italy
Gallus, S:
Ist Ric Farmacol Mario Negri IRCCS IRFMN, Via La Masa 19, I-20156 Milan, Italy
Cortini, B:
Oncol Network Prevent & Res Inst ISPRO, Via Cosiino Il Vecchio 2, I-50139 Florence, Italy
Fernandez, E:
Catalan Inst Oncol ICO, Granvia LHospitalet 199-203, Lhospitalet De Llobregat 199203, Spain
Bellvitge Biomed Res Inst IDIBELL, Granvia LHospitalet 199, Lhospitalet De Llobregat 199203, Spain
Univ Barcelona, Sch Med & Hlth Sci, Dept Clin Sci, Campus Bellvitge,Feixa Lima S-N, Lhospitalet De Llobregat 08907, Spain
Lopez, MJ:
Publ Hlth Agcy Barcelona ASPB, Pl Lesseps 1, Barcelona 08023, Spain
CIBERESP, Av Monforte de Lemos 3-5,Pabellon 11,Planta 0, Madrid 28029, Spain
IIB St Pau, St Antoni Maria Claret 167, Barcelona 08025, Spain
Soriano, JB:
Hosp Univ La Princesa IISP, 62 1st Floor, Madrid 28006, Spain
Lopez-Nicolas, A:
Polytech Univ Cartagena UPCT, Plaza Cronista Isidoro Valverde S-N, Cartagena 30202, Spain
Semple, S:
Univ Stirling, Fac Hlth Sci & Sport, Stirling FK9 4LA, Scotland
Gorini, G:
Oncol Network Prevent & Res Inst ISPRO, Via Cosiino Il Vecchio 2, I-50139 Florence, Italy
Castellano, Y:
Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol ICO, Barcelona, Spain
Fu, M:
Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol ICO, Barcelona, Spain
Ballbe, M:
Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol ICO, Barcelona, Spain
Amalia, B:
Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol ICO, Barcelona, Spain
Tigova, O:
Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol ICO, Barcelona, Spain
Continente, X:
Publ Hlth Agcy Barcelona ASPB, Pl Lesseps 1, Barcelona 08023, Spain
Arechavala, T:
Publ Hlth Agcy Barcelona ASPB, Pl Lesseps 1, Barcelona 08023, Spain
Henderson, E:
Publ Hlth Agcy Barcelona ASPB, Pl Lesseps 1, Barcelona 08023, Spain
Liu, XQ:
Ist Ric Farmacol Mario Negri IRCCS IRFMN, Via La Masa 19, I-20156 Milan, Italy
Bosetti, C:
Ist Ric Farmacol Mario Negri IRCCS IRFMN, Via La Masa 19, I-20156 Milan, Italy
Davoli, E:
Ist Ric Farmacol Mario Negri IRCCS IRFMN, Via La Masa 19, I-20156 Milan, Italy
Colombo, P:
Gallup Int Assoc, Worldwide Independent Network, Ist DOXA, Milan, Italy
O'Donnell, R:
Univ Stirling UNISTIR, Stirling, Scotland
Dobson, R:
Univ Stirling UNISTIR, Stirling, Scotland
Clancy, L:
TobaccoFree Res Inst Ireland TFRI, Dublin, Ireland
Keogan, S:
TobaccoFree Res Inst Ireland TFRI, Dublin, Ireland
Byrne, H:
TobaccoFree Res Inst Ireland TFRI, Dublin, Ireland
Behrakis, P:
George D Behrakis Res Lab HCS, Hellen Canc Soc, Athens, Greece
Tzortzi, A:
George D Behrakis Res Lab HCS, Hellen Canc Soc, Athens, Greece
Vardavas, C:
George D Behrakis Res Lab HCS, Hellen Canc Soc, Athens, Greece
Vyzikidou, VK:
George D Behrakis Res Lab HCS, Hellen Canc Soc, Athens, Greece
Bakellas, G:
George D Behrakis Res Lab HCS, Hellen Canc Soc, Athens, Greece
Mattiampa, G:
George D Behrakis Res Lab HCS, Hellen Canc Soc, Athens, Greece
Boffi, R:
Fdn IRCCS Ist Natl Tumori INT, Milan, Italy
Ruprecht, A:
Fdn IRCCS Ist Natl Tumori INT, Milan, Italy
De Marco, C:
Fdn IRCCS Ist Natl Tumori INT, Milan, Italy
Borgini, A:
Fdn IRCCS Ist Natl Tumori INT, Milan, Italy
Veronese, C:
Fdn IRCCS Ist Natl Tumori INT, Milan, Italy
Bertoldi, M:
Fdn IRCCS Ist Natl Tumori INT, Milan, Italy
Tittarelli, A:
Fdn IRCCS Ist Natl Tumori INT, Milan, Italy
Verdi, S:
ISPRO, Florence, Italy
Chellini, E:
ISPRO, Florence, Italy
Trapero-Bertran, M:
Polytech Univ Cartagena UPCT, Plaza Cronista Isidoro Valverde S-N, Cartagena 30202, Spain
Guerrero, DC:
Polytech Univ Cartagena UPCT, Plaza Cronista Isidoro Valverde S-N, Cartagena 30202, Spain
Radu-Loghin, C:
European Network Smoking & Tobacco Prevent ENSP, Brussels, Belgium
Nguyen, D:
European Network Smoking & Tobacco Prevent ENSP, Brussels, Belgium
Starchenko, P:
European Network Smoking & Tobacco Prevent ENSP, Brussels, Belgium
Ancochea, J:
Hosp Univ La Princesa LISP, Fdn Invest Biomed, Madrid, Spain
Alonso, T:
Hosp Univ La Princesa LISP, Fdn Invest Biomed, Madrid, Spain
Pastor, MT:
Hosp Univ La Princesa LISP, Fdn Invest Biomed, Madrid, Spain
Erro, M:
Hosp Univ La Princesa LISP, Fdn Invest Biomed, Madrid, Spain
Roca, A:
Hosp Univ La Princesa LISP, Fdn Invest Biomed, Madrid, Spain
Perez, P:
Hosp Univ La Princesa LISP, Fdn Invest Biomed, Madrid, Spain
Green Accepted
|